Progress In Diabetes
| ISBN: | 9789372024999 |
| Συγγραφέας: | Anuj Maheshwari |
| Ημ/νία έκδοσης: | 01/2026 |
| Μορφή: | Hardcover |
| Αριθμός έκδοσης: | 1η έκδοση |
| Διαστάσεις: | 24x16 |
| Σελίδες: | 322 |
85,00€8% έκπτωση
78,00€ (συμπ. ΦΠΑ 6%)
23-28 ημέρες Υπό την προϋπόθεση ύπαρξης αποθέματος στον εκδότη
This book presents a comprehensive and future-focused overview of progress in diabetes, encompassing global trends in disease burden, epidemiology, and risk factors, alongside advances in genetics, epigenetics, type 1 diabetes immunotherapy, and emerging early-detection biomarkers. It highlights major therapeutic innovations, including beta-cell regeneration, novel drug classes such as SGLT2 inhibitors, GLP-1 receptor agonists and dual agonists, precision medicine approaches, tailored pharmacotherapy and clinical trials, as well as the role of metabolic surgery and weight-loss interventions in achieving remission. The text explores technology-driven diabetes care, with emphasis on artificial intelligence for prediction and treatment planning, wearable devices, continuous glucose monitoring, closed-loop insulin delivery systems, telemedicine, and the use of big data to advance research. A holistic, complication-aware management approach is emphasized, addressing mental health support, cardiovascular and renal care, prevention of retinopathy and neuropathy, lifestyle modification through diet and exercise, and diabetes management in special populations. In addition, the book examines policy, prevention, and equity-driven strategies, covering public health initiatives, global policies to improve access to care, reduction of disparities in diabetes outcomes, insights from landmark randomized controlled trials, and emerging links between diabetes, cancer, the microbiome, and sports medicine.
Key Features
- Global and genetic outlook: Future trends in diabetes burden, global epidemiology and risk factors, genetics and epigenetics evolution, type 1 diabetes immunotherapy, emerging early detection biomarkers.
- Therapeutic innovations: Beta-cell regeneration advancements, new drug classes: SGLT2-I, GLP-1, dual agonists, precision medicine in diabetes care, pharmacotherapy tailoring and trials, surgery and weight-loss for remission.
- Technology-driven care: AI in prediction and treatment planning, wearables and continuous glucose monitoring, closed-loop insulin delivery systems, telemedicine for remote management, big data powering diabetes research.
- Holistic management approach: Addressing mental health and support, cardiovascular and kidney complication care, retinopathy and neuropathy prevention, lifestyle modification via diet and exercise, diabetes in special populations addressed.
- Policy, equity, and research frontiers: Public health and prevention strategies, global policies for improved care access, tackling disparities in diabetes outcomes, landmark RCTs and their implications, exploring cancer, microbiome, and sports links.
- Future-focused global and genetic insights
- Innovative therapies and drug advancements
- AI-powered, tech-integrated diabetes care
- Holistic, complication-aware management
- Policy, prevention, and equity-driven strategies
Στείλτε μια ερώτηση για το προϊόν
Obesity, Diabetes and Inflammation. Molecular Mechanisms and Clinical Management
100,00€ 114,00€
23-28 ημέρες
Diabetes and Cancer: Association, Mechanism, and Therapeutic Implications
170,00€ 193,00€
23-28 ημέρες
Familial Endocrine Cancer Syndromes. Navigating the Transition of Care for Pediatric and Adolescent Patients
100,00€ 114,00€
23-28 ημέρες
Yen & Jaffe's Reproductive Endocrinology, 9th Edition. Physiology, Pathophysiology, and Clinical Management
233,00€ 262,00€
Άμεσα διαθέσιμο στο κατάστημα
Diabetes Management in Hospitalized Patients. A Comprehensive Clinical Guide
140,00€ 159,00€
23-28 ημέρες
Assessing Human Exposure to Key Chemical Carcinogens. Diagnostic Approaches and Interpretation
